Dicyclomine Hydrochloride and Moxetumomab pasudotox
Determining the interaction of Dicyclomine Hydrochloride and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dicyclomine
Brand name: Bentyl, Dibent, Dicyclocot
Synonyms: Dicyclomine
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dicyclomine Hydrochloride-Moxetumomab Pasudotox-tdfk
- Dicyclomine Hydrochloride-Moxetumomab pasudotox-tdfk Intravenous
- Dicyclomine Hydrochloride-Moxifloxacin
- Dicyclomine Hydrochloride-Moxifloxacin (Systemic)
- Dicyclomine Hydrochloride-Moxifloxacin Hydrochloride
- Dicyclomine Hydrochloride-Moxifloxacin Injection
- Moxetumomab pasudotox-Dicyclomine Injection
- Moxetumomab pasudotox-Dicyclomine Syrup and Oral Solution
- Moxetumomab pasudotox-Dicyclomine Tablets
- Moxetumomab pasudotox-Didanosine
- Moxetumomab pasudotox-Didanosine Delayed-Release Enteric-Coated Capsules
- Moxetumomab pasudotox-Didanosine Oral Solution